Clinical Trials Logo

Filter by:
  • Active, not recruiting  
  • Page [1] ·  Next »
NCT ID: NCT06324591 Active, not recruiting - Crohn Disease Clinical Trials

Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease Patients

Start date: February 3, 2021
Phase: N/A
Study type: Interventional

Crohn's disease (CD), a chronic inflammatory disease affecting the intestine, is characterised by a relapsing course. In 25% of cases, the onset of this disease occurs in childhood. Relevant studies have provided evidence of a key role of gut microbial communities (the microbiota) in triggering or maintaining active gut inflammation, pointing to gut dysbiosis as the main event disrupting the balance of microbial communities Recent evidence suggests that, in addition to the bacterial component, the commensal fungal component also plays a crucial role in CD. The purpose of this prospective, longitudinal, study is to characterise the composition of intestinal bacterial and fungal communities in patients 6-18 years newly diagnosed with Crohn Disease in order to identify a possible association of specific faecal microbial profiles with a severe or mild-to-moderate disease course.

NCT ID: NCT06312436 Active, not recruiting - Hemorrhage Clinical Trials

The AT-REBOA Target Trial

AT-REBOA
Start date: January 1, 2019
Phase:
Study type: Observational

Temporary aortic occlusion can limit haemorrhage, can help to maintain perfusion to the heart and brain, and may be associated with improved survival. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) potentially provides a relatively quick means of achieving this temporary control. In the past years, studies have tried to evaluate the benefit for this method with conflicting results. The previous UK-REBOA trial has not found any benefit in the intervention group and has even hinted at possible harm caused by the intervention. A major limitation of this study is the low number of interventions performed in participating trauma centres and the associated potentially insufficient experience with REBOA. The aim of this study is to evaluate the effectiveness of REBOA in a setting with already experienced providers.

NCT ID: NCT06264375 Active, not recruiting - Physical Activity Clinical Trials

Effect of a Specific and General Physical Exercise Intervention on Gaming and E-Sport Performance

E-SPORT
Start date: January 19, 2024
Phase: N/A
Study type: Interventional

The goal of this randomized control intervention study is to test the effect of i) a specific physical training for e-sport and ii) a general physical training on e-sport performance, compared to iii) not training physically at all. Participants are gamers and e-athletes who play at least >2hours peer week. The main questions it aims to answer are: - Does physical training have an effect on e-sport related abilities (hand grip strength, reaction, anticipation) - Does the training of specific elements, which aim at these abilities "out-game", transfer on the actual skills needed using a keyboard and mouse Participants will be randomly - but mediated by hours of playing per week - distributed in 1 of 3 groups. - Group 1 will 3 times per week for 30 minutes perform a specific physical training with focus on abilities needed in e-sport (grip strength, reaction, anticipation) over a timespan of 8 weeks. - Group 2 will perform a similar physical training (load, intensity) to Group 1, but without specific elements. - Group 3 will serve as control group without any training. Researchers will compare Group 1, Group 2 and Groups 3 to see if the different trainings (Group 1 and Group 2) have different effect on e-sport performance and if no training (Group 3) differs in e-sport performance development.

NCT ID: NCT06135337 Active, not recruiting - Lip Abnormality Clinical Trials

THIODERM ELATE for Augmentation of Very Thin, Thin, and Moderately Thick Lips

TILI
Start date: June 1, 2023
Phase: N/A
Study type: Interventional

This mono-center clinical investigation is intended to assess the safety and effectiveness of THIODERM ELATE for augmentation of very thin and thin lips in comparison with Juvéderm® Ultra 3.

NCT ID: NCT06069752 Active, not recruiting - Clinical trials for Ophthalmological Disorder

Positional Stability and Refractive Behaviour After Implantation of an IOL After Cataract Surgery

Start date: March 8, 2022
Phase:
Study type: Observational

The newest generation Lucia 621 has a step vault design that is claimed to provide excellent positional and refractive predictability. In order to explore the positional stability, anterior chamber depth stability is examined as marker for haptic buckling comparing positional behaviour after conventional and femtosecond-laser assisted cataract surgery.

NCT ID: NCT06056206 Active, not recruiting - Clinical trials for Arteriovenous Fistula Stenosis

The SIR-POBA Shunt Trial

Start date: September 20, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare plain old balloon angioplasty with sirolimus-coated balloon angioplasty in patients with an arteriovenous shunt stenosis. The main question we aim to answer is, how patency is affected by each of the randomised treatment modality.

NCT ID: NCT06056193 Active, not recruiting - Clinical trials for Peripheral Arterial Occlusive Disease

The SIR-POBA Bypass Trial

Start date: September 20, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare plain old balloon angioplasty with sirolimus-coated balloon angioplasty in patients with an infrainguinal venous bypass stenosis. The main question we aim to answer is, how patency is affected by each of the randomised treatment options.

NCT ID: NCT06030908 Active, not recruiting - Clinical trials for Achilles Tendinopathy

Outcome After Surgical Reconstruction of the Achilles Tendon Insertion.

Start date: September 13, 2022
Phase:
Study type: Observational

The purpose of this study is to evaluate the functional outcomes and sports ability after surgical treatment of insertional Achilles tendon tendinopathy using tendon detachment, debridement, and double-row anchor refixation.

NCT ID: NCT05941715 Active, not recruiting - Clinical trials for Neovascular Age-related Macular Degeneration

Faricimab for High-frequent Aflibercept Treated Neovascular Age-related Macular Degeneration

FAN
Start date: July 4, 2023
Phase: Phase 4
Study type: Interventional

Study purpose: To evaluate if previously high-frequent (3-5 weekly) aflibercept treated neovascular age-related macular degeneration (nAMD) can be extended in their treatment interval when switched to faricimab. Primary objective: To assess the efficacy of faricimab compared to aflibercept in terms of durability at 32 weeks by extending treatment interval in previous high-frequent aflibercept treated nAMD.

NCT ID: NCT05933135 Active, not recruiting - Clinical trials for Gastro Intestinal Bleeding

Factor XIII Activity in Gastrointestinal Bleedings

Start date: January 8, 2021
Phase:
Study type: Observational

The aim of this retrospective study is to investigate the relationship between factor XIII activity and the outcome of gastrointestinal bleedings. Since factor XIII is of great importance in haemostasis and plays a key role in stabilizing the fibrin clot, it can be assumed that a deficiency of factor XIII leads to an unfavorable course of gastrointestinal bleedings. Our hypothesis is that early detection of such a deficiency can prevent a more severe course and that substitution of factor XIII contributes to faster cessation of bleeding, improves patient outcome and reduces the number of red cell concentrates required.